Cytek Biosciences, Inc.'s revenue has grown 142% a year over three years, and grown 62% a year over five. Revenue growth, 3-year annual rate: +142% (Medical Devices median +11%). Revenue growth, 5-year rate: +62%, growth has picked up over the last three years. Years of annual history on file: 6, FY2020 to FY2025, as filed.

CTKBCytek Biosciences, Inc.

Healthcare

$5.59+36% 1Y

$5.59

$3.3652 weeks$6.09

Is it growing?

Mixed

Neither accelerating nor breaking down: nothing decisive, though operating margin narrowing (−7.4 points).

1 to watch, 1 neutral, 1 without data

Revenue trend+5% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +62% a year.

Margin direction−7.4 points operating

Trailing-twelve-month operating margin, -23.0% now against -15.6% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is CTKB growing?

Cytek Biosciences, Inc.'s revenue has grown 142% a year over three years, and grown 62% a year over five.

+142%

Revenue growth, 3-year annual rate · Medical Devices median +11% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +62%
Revenue growth, 5-year rate · +142% over three · growth has picked up over the last three years
Years of annual history on file: 6
Years of annual history on file · FY2020 to FY2025, as filed

Details›